arrow
M

Michael Geißler

university hospital carl gustav carus
H指数:44
被引数:6,706

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Quality of life in patients with RAS wild-type metastatic colorectal cancer treated mFOLFOXIRI + panitumumab versus FOLFOXIRI: a prespecified secondary analysis of the phase II VOLFI AIO-KRK 0109 trial

携带RAS野生型转移性结直肠癌患者接受mFOLFOXIRI +帕尼单抗与FOLFOXIRI治疗的生活质量:VOLFI AIO-KRK 0109 II期试验的预设次要分析

2026-09-110
OA
Alternating gemcitabine plus nab-paclitaxel and gemcitabine alone versus continuous gemcitabine plus nab-paclitaxel after induction treatment of metastatic pancreatic cancer (ALPACA): a multicentre, randomised, open-label, phase 2 trial
2024-10-011
PRE
Impact of primary tumor sidedness and sex on prognosis and anti-epidermal growth factor receptor antibody efficacy in BRAF-mutant metastatic colorectal cancer: a pooled analysis of AIO studies FIRE-1, CIOX, FIRE-3, XELAVIRI, and VOLFI
2024-09-010
OAAI
S-1 maintenance therapy in Caucasian patients with metastatic esophagogastric adenocarcinomaefinal results of the randomized AIO MATEO phase II trial

高加索转移性食管胃腺癌患者的S-1维持治疗AIO MATEO II期随机试验的最终结果

2023-06-012
OAAI
Perioperative or only adjuvant gemcitabine plus nab-paclitaxel for resectable pancreatic cancer (NEONAX)da randomized phase II trial of the AIO pancreatic cancer group
2023-01-0173
OAAI
International Tailored Chemotherapy Adjuvant (ITACA) trial, a phase III multicenter randomized trial comparing adjuvant pharmacogenomic-driven chemotherapy versus standard adjuvant chemotherapy in completely resected stage II-IIIA non-small-cell lung cancer
2022-01-0110
OAAI
Survival after secondary liver resection in metastatic colorectal cancer: Comparing data of three prospective randomized European trials (LICC, CELIM, FIRE-3)
2021-12-0410
OA
Safety analysis of the run-in phase (1st and 2nd cohort) of the IMMUNIB trial (AIO-HEP-0218/ass) - An open-label, single-arm phase II study evaluating safety and efficacy of immunotherapy with nivolumab in combination with lenvatinib in advanced stage HCC
2020-09-012
PREAI
Adjuvant MUC vaccination with tecemotide after resection of colorectal liver metastases: a randomized, double-blind, placebo-controlled, multicenter AIO phase II trial (LICC)
2020-08-2314
OAAI